article thumbnail

Why early participant engagement is now a top priority in genetic disease research

pharmaphorum

The DNA of these so-called ‘genetic superheroes’ may contain clues about how to treat severe disease. In the next decade, ‘recontact by genotype’ to identify people at-risk or living with genetic diseases who are eligible for a new therapy or clinical trial will be a major force shaping research and healthcare.

article thumbnail

New Study Suggests Pregnant Women Should Avoid Caffeine Altogether. Here’s Why

XTalks

The results did not differ based on fast or slow caffeine metabolism genotype. Until we learn more, our results suggest it might be prudent to limit or forego caffeine-containing beverages during pregnancy,” Dr. Grantz said in a news release from the NIH.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Evolution in Hepatitis B and C Virus: Can we expect success similar to Hepatitis C in Hepatitis B as well?

Delveinsight

Hepatitis C treatment options, without a doubt, have improved significantly, including pan-genotypic medications that are used to treat all genotypes and subtypes. Typically, pan-genotypic treatments have high cure rates, few side effects, and short treatment durations (usually 8–12 weeks). and GT2 and GT3 with ribavirin.

article thumbnail

Top 30 New Medical Devices of 2024

XTalks

The liquid portion of the blood (serum or plasma) containing antibodies is separated and tested using the Liason Biotrin parvovirus B19 IgG plus test on a Liason XL analyzer. The test collection kit includes a container for stool collection and a separate sampler for hemoglobin testing, requiring only a single stool sample to collect both.

article thumbnail

Why Proviral DNA Drug Resistance Testing is Useful in Guiding Treatment Decisions for HIV-1 Patients

XTalks

Proviral DNA Genotyping. Moreover, drug-resistant virus in proviral DNA could lead to viral rebound if latently infected cells containing drug-resistant proviral DNA become activated. In other words, what is the concordance between proviral resistance results and the historical archive by traditional virus genotyping?

DNA 98
article thumbnail

Adial Pharmaceuticals Provides Update on its ONWARD(TM) Pivotal Phase 3 Trial of AD04 for Treatment of Alcohol Use Disorder

The Pharma Data

ONWARD is investigating Adial’s lead drug candidate, AD04, as a therapeutic agent for the treatment of Alcohol Use Disorder (AUD) in persons with certain target genotypes related to the serotonin transporter and receptor genes. This communication contains certain “forward-looking statements” within the meaning of the U.S.

Trials 52
article thumbnail

BridgeBio Pharma’s Nulibry Approved as First Treatment for Molybdenum Cofactor Deficiency Type A

XTalks

Molybdopterins are a class of cofactors found in most molybdenum-containing and all tungsten-containing enzymes. In the analysis involving 31 patients, 13 were treated with Nulibry and compared to 18 genotype-matched untreated patients from the history control group.